Generic placeholder image

Current Pharmaceutical Design


ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Myocardial Infarction after Rituximab Treatment for Rheumatoid Arthritis: Is there a Link?

Author(s): Alper M. van Sijl, Wilfred van der Weele and Michael T. Nurmohamed

Volume 20, Issue 4, 2014

Page: [496 - 499] Pages: 4

DOI: 10.2174/13816128113199990386

Price: $65


Rituximab is an anti-CD20 monoclonal antibody often used in the treatment of rheumatoid arthritis (RA). Infusion reactions sometimes develop following rituximab administration. Delayed complications are rare. Acute coronary syndromes are listed as sideeffects of rituximab therapy. We report two cases of acute myocardial infarction following rituximab therapy for RA and review the literature regarding cardiac events in patients treated with rituximab. We would like to raise awareness of this possible complication in patients treated with rituximab.

Keywords: Rituximab, rheumatoid arthritis, cardiovascular disease, myocardial infarction.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy